KMPharmaceutical Co Ltd Balance Sheet - KMPharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 698 KRW 2.35% Market Closed

Market Cap: ₩4.5B

Metric	FY2016 Dec 2016	FY2017 Dec 2017	FY2018 Dec 2018	FY2019 Dec 2019	FY2020 Dec 2020	FY2021 Dec 2021	FY2022 Dec 2022	FY2023 Dec 2023	FY2024 Dec 2024	FY2025 Dec 2025
Cash & Cash Equivalents	364m	411m	2.7B	700m	5.7B	2.1B	447.7m	953.4m	221.1m	350.6m
Cash	—	—	—	—	—	—	—	—	—	350.6m
Cash Equivalents	364m	411m	2.7B	700m	5.7B	2.1B	447.7m	953.4m	221.1m	—
Short-Term Investments	9.5B	9.5B	4.1B	793m	152m	565.1m	150m	70.5m	588.9m	0
Total Receivables	54m	55m	3.4B	2.4B	2.8B	3.8B	2.3B	2.3B	1.3B	1.2B
Accounts Receivables	35m	40m	3.4B	2B	2.6B	3.6B	2.3B	1.6B	1.2B	1.2B
Other Receivables	19m	15m	0	341m	225m	171.9m	18.4m	738.9m	85.7m	45.9m
Inventory	—	—	3.3B	3.2B	3.1B	2.8B	2.5B	2.4B	2.4B	2B
Other Current Assets	—	—	170m	366m	270m	637.5m	1B	238.8m	161.9m	184.9m
Total Current Assets	9.9B	10B	13.7B	7.4B	12.1B	9.8B	6.3B	6B	4.7B	3.8B
PP&E Net	—	—	9B	24.8B	27B	25B	22.3B	21.2B	21.1B	20.4B
PP&E Gross	—	—	—	24.8B	27B	25B	22.3B	21.2B	21.1B	20.4B
Accumulated Depreciation	—	—	—	(2.7B)	(3.3B)	(5B)	(7.2B)	(7B)	(7.9B)	(8.9B)
Intangible Assets	—	—	5m	180m	144m	105.7m	67.7m	29.4m	14.2m	20.2m
Note Receivable	—	—	—	—	—	—	—	—	—	60.4m
Long-Term Investments	—	—	9.6B	9.8B	9.9B	11.6B	12.9B	13.7B	14.7B	14B
Other Long-Term Assets	—	—	460m	986m	1.1B	6.1B	9.6B	9.7B	8.4B	8.2B
Total Assets	9.9B	10B	32.7B	43.1B	50.2B	52.7B	51.3B	50.6B	49B	46.4B
Accounts Payable	—	—	2.2B	931m	743m	1.3B	636.4m	802.1m	998.7m	1.2B
Accrued Liabilities	—	—	—	778m	694m	898.1m	603.1m	1.3B	856.9m	828m
Short-Term Debt	0	0	500m	500m	1B	1B	2.5B	6B	4B	4.8B
Current Portion of Long-Term Debt	—	1.5B	501m	866m	324m	3.4B	8.3B	3.3B	3.1B	4.8B
Other Current Liabilities	0	0	418m	267m	347m	886.8m	435.3m	494.1m	324.6m	188.4m
Deferred Revenue	—	—	—	89.7m	86.4m	557.6m	222.4m	38.3m	125.5m	78.4m
Total Current Liabilities	0	1.5B	3.6B	3.3B	3.1B	7.5B	12.5B	11.9B	9.3B	11.9B
Long-Term Debt	1.4B	0	5.3B	15.6B	6.2B	5.3B	2.4B	3.1B	7B	6.2B
Deferred Income Tax	22m	14m	—	—	—	—	—	—	—	—
Other Liabilities	—	—	35m	20m	186m	34.3m	10.1m	59.1m	41.9m	61.8m
Total Liabilities	1.5B	1.5B	8.9B	18.9B	9.5B	12.8B	15B	15.1B	16.4B	18.1B
Common Stock	450m	450m	2B	2.1B	2.8B	2.8B	2.8B	2.8B	2.8B	2.8B
Retained Earnings	7m	22m	(3.2B)	(4.1B)	(3.6B)	(4.2B)	(8.1B)	(9.5B)	(14B)	13.6B
Additional Paid In Capital	8B	8B	25B	26.9B	42.3B	42.3B	42.3B	42.3B	42.3B	10.7B
Unrealized Security Profit/Loss	—	—	—	(769m)	(972m)	(1.2B)	(881.3m)	(410.6m)	1.3B	918.6m
Treasury Stock	—	—	—	0	0	(166.6k)	(166.6k)	(166.6k)	(166.6k)	(166.6k)
Other Equity	—	—	0	—	236m	236.5m	236.5m	236.5m	236.5m	236.5m
Total Equity	8.5B	8.5B	23.8B	24.2B	40.8B	39.9B	36.3B	35.5B	32.6B	28.3B
Total Liabilities & Equity	9.9B	10B	32.7B	43.1B	50.2B	52.7B	51.3B	50.6B	49B	46.4B
Common Shares Outstanding	945k	945k	4.2m	4.5m	5.6m	5.6m	5.6m	5.6m	5.6m	5.6m